Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
for
Cataract
Location: San Francisco CA, Overland Park KS, Minneapolis MN,
Sponsor: Chakshu Research, Inc.
Sex: All
Age: 50 - 70+
Code: NCT00793091
Phase 2, Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: San Francisco CA, Reno NV, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase 3, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: San Francisco CA, Palo Alto CA, Santa Rosa CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: San Francisco CA, Reno NV, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
for
Thyroid Eye Disease, TED, Graves Orbitopathy
Location: San Francisco CA, Las Vegas NV, Reno NV, Canoga Park CA,
Sponsor: Sling Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07753603
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
New
A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)
for
HIV
Location: San Francisco CA, Toronto, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07850609
Phase 2, Recruiting
Personalized HIV and STI Testing Tool
for
Risk Reduction, HIV,
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.
Sex: Male
Age: 18 - 29
Code: NCT03109899
Recruiting
A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW
for
HIV Prevention, Pre-exposure Prophylaxis (PrEP), Risk Reduction,
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.
Sex: Male
Age: 18+
Code: NCT05474313
Recruiting
PrEPsmart 2-1-1 Pilot
for
HIV-1-infection
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.
Sex: Male
Age: 18+
Code: NCT06631365
Phase 2, Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: San Francisco CA, Nashville TN, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase 1, Recruiting
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
for
HIV
Location: San Francisco CA, Houston TX, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT07390955
Phase 1, Recruiting
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
for
Glioblastoma
Location: San Francisco CA, Los Angeles CA, Scottsdale AZ,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT07195591
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: San Francisco CA, Irvine CA, Eugene OR, Happy Valley OR,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: San Francisco CA, Berkeley CA, San Mateo CA, Vallejo CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: San Francisco CA, South San Francisco CA, Oakland CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
TruGraf® Long-term Clinical Outcomes Study
for
Kidney Transplant Rejection
Location: San Francisco CA, Sacramento CA, Fresno CA,
Sponsor: Transplant Genomics, Inc.
Sex: All
Age: 18+
Code: NCT04491552
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for
Primary Biliary Cholangitis
Location: San Francisco CA, South San Francisco CA,